Incorporating an exercise detection, grading, and hormone dosing algorithm into the artificial pancreas using accelerometry and heart rate

Journal of Diabetes Science and Technology

Volumn 9, Issue 6, 2015, Pages 1175-1184

  Jacobs, Peter G ^a   Resalat, Navid ^a   Youssef, Joseph El ^b   Reddy, Ravi ^a   Branigan, Deborah ^b   Preiser, Nicholas ^a   Condon, John ^a   Castle, Jessica ^b  

^a Oregon Health and Science University Department of Biomedical Engineering   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Accelerometer; Energy expenditure; Exercise; Glucoregulatory model; Heart rate; Hypoglycemia

Indexed keywords

INSULIN; ANTIDIABETIC AGENT; BIOLOGICAL MARKER; GLUCAGON; GLUCOSE BLOOD LEVEL;

ACCELEROMETRY; ADULT; ALGORITHM; ARTICLE; ARTIFICIAL PANCREAS; CLINICAL ARTICLE; COMPUTER MODEL; ENERGY EXPENDITURE; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MATHEMATICAL PARAMETERS; SENSITIVITY AND SPECIFICITY; TREADMILL EXERCISE; ACTIMETRY; BIOLOGICAL MODEL; BLOOD; COMPUTER SIMULATION; DEVICES; DIABETES MELLITUS, TYPE 1; DOSE CALCULATION; DRUG EFFECTS; ENERGY METABOLISM; EQUIPMENT DESIGN; EXERCISE; EXERCISE TEST; METABOLISM; PATHOPHYSIOLOGY; PREDICTIVE VALUE; STATISTICAL MODEL; TIME FACTOR;

ACTIGRAPHY; ALGORITHMS; BIOMARKERS; BLOOD GLUCOSE; COMPUTER SIMULATION; DIABETES MELLITUS, TYPE 1; DRUG DOSAGE CALCULATIONS; ENERGY METABOLISM; EQUIPMENT DESIGN; EXERCISE; EXERCISE TEST; GLUCAGON; HEART RATE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LINEAR MODELS; MODELS, BIOLOGICAL; PANCREAS, ARTIFICIAL; PREDICTIVE VALUE OF TESTS; TIME FACTORS;

EID: 84992377647     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296815609371     Document Type: Article

References (29)

1. Basu R, Johnson ML, Kudva YC, Basu A. Exercise, hypoglycemia, and type 1 diabetes. Diabetes Technol Ther. 2014;16(6):331-337.
2. Stenerson M, Cameron F, Wilson DM, et al. The impact of accelerometer and heart rate data on hypoglycemia mitigation in type 1 diabetes. J Diabetes Sci Technol. 2014;8(1):64-69.
3. Stenerson M, Cameron F, Payne SR, et al. The impact of accelerometer use in exercise-associated hypoglycemia prevention in type 1 diabetes. J Diabetes Sci Technol. 2015;9(1):80-85.
4. Turksoy K, Bayrak ES, Quinn L, Littlejohn E, Cinar A. Multivariable adaptive closed-loop control of an artificial pancreas without meal and activity announcement. Diabetes Technol Ther. 2013;15(5):386-400.
5. Turksoy K, Quinn LT, Littlejohn E, Cinar A. An integrated multivariable artificial pancreas control system. J Diabetes Sci Technol. 2014;8(3):498-507.
6. Breton MD, Brown SA, Karvetski CH, et al. Adding heart rate signal to a control-to-range artificial pancreas system improves the protection against hypoglycemia during exercise in type 1 diabetes. Diabetes Technol Ther. 2014;16(8):506-511.
7. Butte NF, Ekelund U, Westerterp KR. Assessing physical activity using wearable monitors: measures of physical activity. Med Sci Sports Exerc. 2012;44(1 suppl 1):S5-S12.
8. Dasanayake IS, Bevier WC, Castorino K, et al. Early detection of physical activity for people with type 1 diabetes mellitus [published online ahead of print June 30, 2015]. J Diabetes Sci Technol. 2015.
9. Rothney MP, Neumann M, Beziat A, Chen KY. An artificial neural network model of energy expenditure using nonintegrated acceleration signals. J Applied Physiol. 2007;103(4):1419-1427.
10. Staudenmayer J, Pober D, Crouter S, Bassett D, Freedson P. An artificial neural network to estimate physical activity energy expenditure and identify physical activity type from an accelerometer. J Applied Physiol. 2009;107(4):1300-1307.
11. Zakeri I, Adolph AL, Puyau MR, Vohra FA, Butte NF. Application of cross-sectional time series modeling for the prediction of energy expenditure from heart rate and accelerometry. J Applied Physiol. 2008;104(6):1665-1673.
12. Jacobs PG, El Youssef J, Castle J, et al. Automated control of an adaptive bihormonal, dual-sensor artificial pancreas and evaluation during inpatient studies. IEEE Trans Biomed Eng. 2014;61(10):2569-2581.
13. Gopakumaran B, Duman HM, Overholser DP, et al. A novel insulin delivery algorithm in rats with type 1 diabetes: the fading memory proportional-derivative method. Artif Organs. 2005;29(8):599-607.
14. Castle JR, Engle JM, El Youssef J, et al. Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type 1 diabetes. Diabetes Care. 2010;33(6):1282-1287.
15. Hernandez-Ordonez M, Campos-Delgado DU. An extension to the compartmental model of type 1 diabetic patients to reproduce exercise periods with glycogen depletion and replenishment. J Biomech. 2008;41(4):744-752.
16. Hovorka R, Canonico V, Chassin LJ, et al. Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. Physiol Meas. 2004;25(4):905-920.
17. Lv D, Breton MD, Farhy LS. Pharmacokinetics modeling of exogenous glucagon in type 1 diabetes mellitus patients. Diabetes Technol Ther. 2013;15(11):935-941.
18. Wilinska ME, Chassin LJ, Schaller HC, Schaupp L, Pieber TR, Hovorka R. Insulin kinetics in type-I diabetes: continuous and bolus delivery of rapid acting insulin. IEEE Trans Biomed Eng. 2005;52(1):3-12.
19. Man CD, Micheletto F, Lv D, Breton M, Kovatchev B, Cobelli C. The UVA/PADOVA type 1 diabetes simulator: new features. J Diabetes Sci Technol. 2014;8(1):26-34.
20. Bakhtiani PA, El Youssef J, Duell AK, et al. Factors affecting the success of glucagon delivered during an automated closedloop system in type 1 diabetes. J Diabetes Complications. 2015;29(1):93-98.
21. El Youssef J, Castle JR, Bakhtiani PA, et al. Quantification of the glycemic response to microdoses of subcutaneous glucagon at varying insulin levels. Diabetes Care. 2014;37(11): 3054-3060.
22. Wilinska ME, Chassin LJ, Acerini CL, Allen JM, Dunger DB, Hovorka R. Simulation environment to evaluate closed-loop insulin delivery systems in type 1 diabetes. J Diabetes Sci Technol. 2010;4(1):132-144.
23. Garcia-Garcia F, Kumareswaran K, Hovorka R, Hernando ME. Quantifying the acute changes in glucose with exercise in type 1 diabetes: a systematic review and meta-analysis. Sports Med. 2015;45(4):587-599.
24. Yardley JE, Kenny GP, Perkins BA, et al. Resistance versus aerobic exercise: acute effects on glycemia in type 1 diabetes. Diabetes Care. 2013;36(3):537-542.
25. McMahon SK, Ferreira LD, Ratnam N, et al. Glucose requirements to maintain euglycemia after moderate-intensity afternoon exercise in adolescents with type 1 diabetes are increased in a biphasic manner. J Clin Endocrinol Metab. 2007;92(3):963-968.
26. MacDonald MJ. Postexercise late-onset hypoglycemia in insulin- dependent diabetic patients. Diabetes Care. 1987;10(5): 584-588.
27. Haidar A, Wilinska ME, Graveston JA, Hovorka R. Stochastic virtual population of subjects with type 1 diabetes for the assessment of closed-loop glucose controllers. IEEE Trans Biomed Eng. 2013;60(12):3524-3533.
28. Castle J, El Youssef J, Bakhtiani P, et al. Effect of repeated glucagon doses on hepatic glycogen in type 1 diabetes: implications for a bi-hormonal closed-loop system [published online ahead of print September 4, 2015]. Diabetes Care.
29. Visentin R, Dalla Man C, Kudva YC, Basu A, Cobelli C. Circadian variability of insulin sensitivity: physiological input for in silico artificial pancreas. Diabetes Technol Ther. 2015;17(1):1-7.